2015
DOI: 10.2174/0929867322666151015120804
|View full text |Cite
|
Sign up to set email alerts
|

Current and Future Chemotherapy for Chagas Disease

Abstract: American trypanosomiasis, commonly called Chagas disease, is one of the most neglected illnesses in the world and remains one of the most prevalent chronic infectious diseases of Latin America with thousands of new cases every year. The only treatments available have been introduced five decades ago. They have serious, undesirable side effects and disputed benefits in the chronic stage of the disease -a characteristic and debilitating cardiomyopathy and/or megavisceras. Several laboratories have therefore focu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
36
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 49 publications
(38 citation statements)
references
References 49 publications
0
36
0
Order By: Relevance
“…There is an estimate of 6–7 million people currently infected with T. cruzi , and the cost of treatment for CD remains substantial. Since the discovery of T. cruzi as the etiological agent of CD, a cure has been pursued, but no improvements in chemotherapy have been made regarding safety or effectiveness, despite a half century of intense research (Gaspar et al, 2015). …”
Section: Introductionmentioning
confidence: 99%
“…There is an estimate of 6–7 million people currently infected with T. cruzi , and the cost of treatment for CD remains substantial. Since the discovery of T. cruzi as the etiological agent of CD, a cure has been pursued, but no improvements in chemotherapy have been made regarding safety or effectiveness, despite a half century of intense research (Gaspar et al, 2015). …”
Section: Introductionmentioning
confidence: 99%
“…By contrast, in T. cruzi any perturbation of the furan was detrimental to activity with all analogues greater than 100 µM, the only exception being nitro compound 32 with slightly improved activity (entry 6). For L. major, 5-methyl and 5-nitro substitution was tolerated (entries 2 and 6) but changing the substitution position or adding electron-withdrawing groups gave reduced activity (entries [3][4][5]. The compounds showed generally moderate to no activity against HeLa with nitro compound 32 once again the exception at 0.38 µM.…”
Section: Biological Testingmentioning
confidence: 99%
“…Three such diseases are African sleeping sickness, 4 Chagas disease 5 and Leishmaniasis, 6 spread by the related kinetoplastid parasitic causative agents Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp, respectively. These parasites are present in tropical regions across the world; T. brucei in subSaharan Africa, T. cruzi in South America and increasingly in North America 7 and Leishmania throughout the tropics and sub-tropics.…”
Section: Introductionmentioning
confidence: 99%
“…and Trypanosoma cruzi, respectively, affecting millions of people worldwide (Gaspar et al 2015). The available therapeutic arsenal for the treatment of these diseases is very limited and highly toxic, based on the pentavalent antimonials, amphotericin B, miltefosine and benznidazole (Passero et al 2014).…”
Section: Introductionmentioning
confidence: 99%